UNSPSC 51342000: Antiviral azoles

Antiviral drugs made from five membered rings containing a nitrogen atom.

UNSPSC 51342000 Antiviral azoles is a Class code that represents pharmaceutical products, though recent state and local procurement activity tagged under it diverges significantly from the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets—antibiotics, not antivirals. Seminole County, Florida released an IFB on June 30, 2026, for procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—opioid reversal agents and drug disposal systems, also outside the antiviral-azole scope. State and local health departments and county community health agencies are the issuing bodies visible in recent postings, but the actual commodity mix being procured bears little alignment with antiviral azoles as a product family.

Activity is sparse and geographically limited to Illinois and Florida in the recent record. The Illinois award was completed on an IFB basis with a 12-month initial term and renewal options through year 3; Chartwell Rx LLC was selected as the lowest responsive and responsible bidder with no business enterprise set-asides applied. The Seminole County IFB carried a July 26, 2023 response deadline (substantially older than the posting date of June 30, 2026, suggesting potential data inconsistency in the source record) and required quarterly deliveries to a specified community health building, E-Verify compliance, drug-free workplace certification, and potential FEMA-funded compliance including Clean Air Act and Federal Water Pollution Control Act adherence. The code shows little relevant recent activity aligned with its antiviral-azole scope; procurement professionals should verify whether opportunities tagged to this code actually require antivirals or whether the tagging reflects broader pharmaceutical-category matching.